TW202434621A - Polynucleotide construct and related viral vectors and methods - Google Patents

TW202434621A - Polynucleotide construct and related viral vectors and methods - Google Patents

Info

Publication number

TW202434621A

TW202434621A TW112142462A TW112142462A TW202434621A TW 202434621 A TW202434621 A TW 202434621A TW 112142462 A TW112142462 A TW 112142462A TW 112142462 A TW112142462 A TW 112142462A TW 202434621 A TW202434621 A TW 202434621A Authority

TW

Taiwan

Prior art keywords

seq

construct

amino acid

nucleotide sequence

acid sequence

Prior art date

2022-11-04

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 108
• 239000013603 viral vector Substances 0.000 title claims abstract description 48
• 102000040430 polynucleotide Human genes 0.000 title description 33
• 108091033319 polynucleotide Proteins 0.000 title description 33
• 239000002157 polynucleotide Substances 0.000 title description 33
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims abstract description 157
• 239000013598 vector Substances 0.000 claims abstract description 102
• 125000003729 nucleotide group Chemical group 0.000 claims description 868
• 239000002773 nucleotide Substances 0.000 claims description 867
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 762
• 210000004027 cell Anatomy 0.000 claims description 266
• 230000014509 gene expression Effects 0.000 claims description 227
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 138
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 134
• 229920001184 polypeptide Polymers 0.000 claims description 130
• 230000003834 intracellular effect Effects 0.000 claims description 107
• 239000003446 ligand Substances 0.000 claims description 80
• 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 claims description 77
• 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 claims description 77
• 238000003776 cleavage reaction Methods 0.000 claims description 76
• 230000007017 scission Effects 0.000 claims description 74
• 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims description 68
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims description 68
• 102000015696 Interleukins Human genes 0.000 claims description 67
• 108010063738 Interleukins Proteins 0.000 claims description 67
• 108090000623 proteins and genes Proteins 0.000 claims description 63
• 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 claims description 58
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims description 58
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 53
• 206010028980 Neoplasm Diseases 0.000 claims description 50
• 210000000130 stem cell Anatomy 0.000 claims description 48
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 47
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 47
• 102100026879 Interleukin-2 receptor subunit beta Human genes 0.000 claims description 42
• 101710154942 Interleukin-2 receptor subunit beta Proteins 0.000 claims description 39
• 102100026234 Cytokine receptor common subunit gamma Human genes 0.000 claims description 38
• 101710189311 Cytokine receptor common subunit gamma Proteins 0.000 claims description 38
• 102000002467 interleukin receptors Human genes 0.000 claims description 35
• 108010093036 interleukin receptors Proteins 0.000 claims description 35
• 201000011510 cancer Diseases 0.000 claims description 31
• 102000004961 Furin Human genes 0.000 claims description 27
• 108090001126 Furin Proteins 0.000 claims description 27
• -1 anti-CD3 Proteins 0.000 claims description 20
• 238000000338 in vitro Methods 0.000 claims description 17
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 17
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 16
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 16
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 16
• 101001063392 Homo sapiens Lymphocyte function-associated antigen 3 Proteins 0.000 claims description 15
• 102100030984 Lymphocyte function-associated antigen 3 Human genes 0.000 claims description 15
• 238000001727 in vivo Methods 0.000 claims description 15
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 14
• 229960002930 sirolimus Drugs 0.000 claims description 11
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 10
• 239000011724 folic acid Substances 0.000 claims description 10
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 10
• 230000002463 transducing effect Effects 0.000 claims description 9
• 229940014144 folate Drugs 0.000 claims description 8
• 229940126530 T cell activator Drugs 0.000 claims description 7
• 230000001588 bifunctional effect Effects 0.000 claims description 7
• 108020004705 Codon Proteins 0.000 claims description 6
• 108020005004 Guide RNA Proteins 0.000 claims description 6
• 210000004698 lymphocyte Anatomy 0.000 claims description 5
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 claims description 4
• 102100031780 Endonuclease Human genes 0.000 claims description 3
• 108010042407 Endonucleases Proteins 0.000 claims description 3
• 231100000433 cytotoxic Toxicity 0.000 claims description 3
• 230000001472 cytotoxic effect Effects 0.000 claims description 3
• 150000002540 isothiocyanates Chemical class 0.000 claims description 3
• 102000003675 cytokine receptors Human genes 0.000 abstract 1
• 108010057085 cytokine receptors Proteins 0.000 abstract 1
• 239000002245 particle Substances 0.000 description 110
• 230000001177 retroviral effect Effects 0.000 description 55
• 230000026683 transduction Effects 0.000 description 47
• 238000010361 transduction Methods 0.000 description 47
• 230000003612 virological effect Effects 0.000 description 47
• 239000013612 plasmid Substances 0.000 description 44
• 102000004169 proteins and genes Human genes 0.000 description 44
• 108010003533 Viral Envelope Proteins Proteins 0.000 description 38
• 241000700605 Viruses Species 0.000 description 37
• 239000000427 antigen Substances 0.000 description 36
• 108091007433 antigens Proteins 0.000 description 36
• 102000036639 antigens Human genes 0.000 description 36
• 239000003623 enhancer Substances 0.000 description 36
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 34
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 34
• 230000011664 signaling Effects 0.000 description 33
• 239000000203 mixture Substances 0.000 description 32
• 150000007523 nucleic acids Chemical group 0.000 description 30
• 230000004913 activation Effects 0.000 description 29
• 230000032823 cell division Effects 0.000 description 27
• 102000005962 receptors Human genes 0.000 description 26
• 108020003175 receptors Proteins 0.000 description 26
• 101800001494 Protease 2A Proteins 0.000 description 25
• 101800001066 Protein 2A Proteins 0.000 description 25
• 239000012634 fragment Substances 0.000 description 25
• 102220003351 rs387906411 Human genes 0.000 description 25
• 241000711975 Vesicular stomatitis virus Species 0.000 description 24
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 24
• 102000039446 nucleic acids Human genes 0.000 description 24
• 108020004707 nucleic acids Proteins 0.000 description 24
• 238000012546 transfer Methods 0.000 description 24
• 230000004927 fusion Effects 0.000 description 23
• 230000008685 targeting Effects 0.000 description 23
• 102000003886 Glycoproteins Human genes 0.000 description 22
• 108090000288 Glycoproteins Proteins 0.000 description 22
• 238000006471 dimerization reaction Methods 0.000 description 22
• 201000010099 disease Diseases 0.000 description 22
• 150000001413 amino acids Chemical class 0.000 description 20
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 19
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 19
• 210000004779 membrane envelope Anatomy 0.000 description 19
• 241000713666 Lentivirus Species 0.000 description 18
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 18
• 241001430294 unidentified retrovirus Species 0.000 description 18
• 108091006027 G proteins Proteins 0.000 description 17
• 102000030782 GTP binding Human genes 0.000 description 17
• 108091000058 GTP-Binding Proteins 0.000 description 17
• 125000006850 spacer group Chemical group 0.000 description 17
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 16
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 16
• 238000009472 formulation Methods 0.000 description 15
• 102000004127 Cytokines Human genes 0.000 description 14
• 108090000695 Cytokines Proteins 0.000 description 14
• 101800001467 Envelope glycoprotein E2 Proteins 0.000 description 14
• 102100034349 Integrase Human genes 0.000 description 14
• 101800001271 Surface protein Proteins 0.000 description 14
• 102100025237 T-cell surface antigen CD2 Human genes 0.000 description 14
• 210000002865 immune cell Anatomy 0.000 description 14
• 238000004519 manufacturing process Methods 0.000 description 14
• 238000004806 packaging method and process Methods 0.000 description 14
• 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 description 13
• 108091008874 T cell receptors Proteins 0.000 description 13
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 13
• 108010076504 Protein Sorting Signals Proteins 0.000 description 12
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 12
• 238000005538 encapsulation Methods 0.000 description 12
• 230000005931 immune cell recruitment Effects 0.000 description 12
• 238000007911 parenteral administration Methods 0.000 description 12
• 230000003213 activating effect Effects 0.000 description 11
• 102000027257 transmembrane receptors Human genes 0.000 description 11
• 108091008578 transmembrane receptors Proteins 0.000 description 11
• 241000713813 Gibbon ape leukemia virus Species 0.000 description 10
• 241000725303 Human immunodeficiency virus Species 0.000 description 10
• 238000004891 communication Methods 0.000 description 10
• 230000000139 costimulatory effect Effects 0.000 description 10
• 208000015181 infectious disease Diseases 0.000 description 10
• 108091028043 Nucleic acid sequence Proteins 0.000 description 9
• 239000002202 Polyethylene glycol Substances 0.000 description 9
• 239000008186 active pharmaceutical agent Substances 0.000 description 9
• 230000006870 function Effects 0.000 description 9
• 229920001223 polyethylene glycol Polymers 0.000 description 9
• 241000217815 Bas-Congo tibrovirus Species 0.000 description 8
• 241000714177 Murine leukemia virus Species 0.000 description 8
• 206010039491 Sarcoma Diseases 0.000 description 8
• 108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 8
• 102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 8
• 108091023045 Untranslated Region Proteins 0.000 description 8
• 241001517166 Vesicular stomatitis Alagoas virus Species 0.000 description 8
• 241000711973 Vesicular stomatitis Indiana virus Species 0.000 description 8
• 241000711959 Vesicular stomatitis New Jersey virus Species 0.000 description 8
• 208000032839 leukemia Diseases 0.000 description 8
• 239000008194 pharmaceutical composition Substances 0.000 description 8
• 230000001105 regulatory effect Effects 0.000 description 8
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 7
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 7
• 108010067390 Viral Proteins Proteins 0.000 description 7
• 230000001086 cytosolic effect Effects 0.000 description 7
• 230000004068 intracellular signaling Effects 0.000 description 7
• 230000004083 survival effect Effects 0.000 description 7
• 238000011282 treatment Methods 0.000 description 7
• 102100038080 B-cell receptor CD22 Human genes 0.000 description 6
• 206010009944 Colon cancer Diseases 0.000 description 6
• 241000701022 Cytomegalovirus Species 0.000 description 6
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 6
• 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 6
• 101000679851 Homo sapiens Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 6
• 108010002350 Interleukin-2 Proteins 0.000 description 6
• 102000000588 Interleukin-2 Human genes 0.000 description 6
• 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 6
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 6
• 210000004899 c-terminal region Anatomy 0.000 description 6
• 230000000694 effects Effects 0.000 description 6
• 230000002458 infectious effect Effects 0.000 description 6
• 230000010354 integration Effects 0.000 description 6
• 230000035772 mutation Effects 0.000 description 6
• 210000000822 natural killer cell Anatomy 0.000 description 6
• 239000000243 solution Substances 0.000 description 6
• 230000000638 stimulation Effects 0.000 description 6
• 102000003390 tumor necrosis factor Human genes 0.000 description 6
• 102100038077 CD226 antigen Human genes 0.000 description 5
• 241001481489 Carajas vesiculovirus Species 0.000 description 5
• 102100024423 Carbonic anhydrase 9 Human genes 0.000 description 5
• 102000000844 Cell Surface Receptors Human genes 0.000 description 5
• 108010001857 Cell Surface Receptors Proteins 0.000 description 5
• 241001481494 Chandipura vesiculovirus Species 0.000 description 5
• 241001481490 Cocal vesiculovirus Species 0.000 description 5
• 241000501789 Cocal virus Species 0.000 description 5
• 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 5
• 101710121417 Envelope glycoprotein Proteins 0.000 description 5
• 101000884298 Homo sapiens CD226 antigen Proteins 0.000 description 5
• 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 description 5
• 101000589305 Homo sapiens Natural cytotoxicity triggering receptor 2 Proteins 0.000 description 5
• 101000633778 Homo sapiens SLAM family member 5 Proteins 0.000 description 5
• 101000633786 Homo sapiens SLAM family member 6 Proteins 0.000 description 5
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 5
• 241001481491 Isfahan vesiculovirus Species 0.000 description 5
• 241001481492 Maraba vesiculovirus Species 0.000 description 5
• 241000712079 Measles morbillivirus Species 0.000 description 5
• 101100236305 Mus musculus Ly9 gene Proteins 0.000 description 5
• 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 description 5
• 108010004217 Natural Cytotoxicity Triggering Receptor 1 Proteins 0.000 description 5
• 102100032870 Natural cytotoxicity triggering receptor 1 Human genes 0.000 description 5
• 102100032851 Natural cytotoxicity triggering receptor 2 Human genes 0.000 description 5
• 108010042215 OX40 Ligand Proteins 0.000 description 5
• 206010033128 Ovarian cancer Diseases 0.000 description 5
• 206010061535 Ovarian neoplasm Diseases 0.000 description 5
• 241001504519 Papio ursinus Species 0.000 description 5
• 108091005804 Peptidases Proteins 0.000 description 5
• 239000004365 Protease Substances 0.000 description 5
• 102100029216 SLAM family member 5 Human genes 0.000 description 5
• 102100029197 SLAM family member 6 Human genes 0.000 description 5
• 108010074687 Signaling Lymphocytic Activation Molecule Family Member 1 Proteins 0.000 description 5
• 102100029215 Signaling lymphocytic activation molecule Human genes 0.000 description 5
• 108010003723 Single-Domain Antibodies Proteins 0.000 description 5
• 230000006044 T cell activation Effects 0.000 description 5
• 102100026890 Tumor necrosis factor ligand superfamily member 4 Human genes 0.000 description 5
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 5
• 239000011230 binding agent Substances 0.000 description 5
• 238000002659 cell therapy Methods 0.000 description 5
• 239000003795 chemical substances by application Substances 0.000 description 5
• 208000029742 colonic neoplasm Diseases 0.000 description 5
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 5
• 210000004263 induced pluripotent stem cell Anatomy 0.000 description 5
• SOAPXKSPJAZNGO-WDSKDSINSA-N (2s)-2-[[(1s)-1,3-dicarboxypropyl]carbamoylamino]pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)N[C@H](C(O)=O)CCC(O)=O SOAPXKSPJAZNGO-WDSKDSINSA-N 0.000 description 4
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
• BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 description 4
• 108010008014 B-Cell Maturation Antigen Proteins 0.000 description 4
• 102000006942 B-Cell Maturation Antigen Human genes 0.000 description 4
• 208000003174 Brain Neoplasms Diseases 0.000 description 4
• 206010006187 Breast cancer Diseases 0.000 description 4
• 208000026310 Breast neoplasm Diseases 0.000 description 4
• 102100027207 CD27 antigen Human genes 0.000 description 4
• 241001502567 Chikungunya virus Species 0.000 description 4
• 108020004414 DNA Proteins 0.000 description 4
• 241000712469 Fowl plague virus Species 0.000 description 4
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 4
• 101000971538 Homo sapiens Killer cell lectin-like receptor subfamily F member 1 Proteins 0.000 description 4
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 4
• 101000884270 Homo sapiens Natural killer cell receptor 2B4 Proteins 0.000 description 4
• 101000764622 Homo sapiens Transmembrane and immunoglobulin domain-containing protein 2 Proteins 0.000 description 4
• 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 4
• 108010061833 Integrases Proteins 0.000 description 4
• 102100025390 Integrin beta-2 Human genes 0.000 description 4
• 102100021458 Killer cell lectin-like receptor subfamily F member 1 Human genes 0.000 description 4
• 239000000232 Lipid Bilayer Substances 0.000 description 4
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 4
• 241000725171 Mokola lyssavirus Species 0.000 description 4
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 4
• 108010004222 Natural Cytotoxicity Triggering Receptor 3 Proteins 0.000 description 4
• 102100032852 Natural cytotoxicity triggering receptor 3 Human genes 0.000 description 4
• 102100038082 Natural killer cell receptor 2B4 Human genes 0.000 description 4
• 241000526636 Nipah henipavirus Species 0.000 description 4
• 102100024304 Protachykinin-1 Human genes 0.000 description 4
• 241000711798 Rabies lyssavirus Species 0.000 description 4
• 241000713311 Simian immunodeficiency virus Species 0.000 description 4
• 241000710960 Sindbis virus Species 0.000 description 4
• 102100037346 Substance-P receptor Human genes 0.000 description 4
• 102100026224 Transmembrane and immunoglobulin domain-containing protein 2 Human genes 0.000 description 4
• 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 4
• 241000710959 Venezuelan equine encephalitis virus Species 0.000 description 4
• 241000710951 Western equine encephalitis virus Species 0.000 description 4
• 210000000612 antigen-presenting cell Anatomy 0.000 description 4
• 239000007864 aqueous solution Substances 0.000 description 4
• 108700004025 env Genes Proteins 0.000 description 4
• 101150030339 env gene Proteins 0.000 description 4
• OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
• 238000011534 incubation Methods 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 230000003993 interaction Effects 0.000 description 4
• 239000003550 marker Substances 0.000 description 4
• 201000008968 osteosarcoma Diseases 0.000 description 4
• 230000001566 pro-viral effect Effects 0.000 description 4
• 230000008569 process Effects 0.000 description 4
• 230000035755 proliferation Effects 0.000 description 4
• 238000003753 real-time PCR Methods 0.000 description 4
• 238000009877 rendering Methods 0.000 description 4
• 230000010076 replication Effects 0.000 description 4
• 239000000126 substance Substances 0.000 description 4
• 230000001018 virulence Effects 0.000 description 4
• YURDCJXYOLERLO-LCYFTJDESA-N (2E)-5-methyl-2-phenylhex-2-enal Chemical compound CC(C)C\C=C(\C=O)C1=CC=CC=C1 YURDCJXYOLERLO-LCYFTJDESA-N 0.000 description 3
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
• 108010082808 4-1BB Ligand Proteins 0.000 description 3
• 241000714175 Abelson murine leukemia virus Species 0.000 description 3
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 3
• 206010004593 Bile duct cancer Diseases 0.000 description 3
• 108700012439 CA9 Proteins 0.000 description 3
• 102100032937 CD40 ligand Human genes 0.000 description 3
• 102100037904 CD9 antigen Human genes 0.000 description 3
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 3
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 3
• 206010008342 Cervix carcinoma Diseases 0.000 description 3
• 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 3
• 101710091045 Envelope protein Proteins 0.000 description 3
• 101710088083 Glomulin Proteins 0.000 description 3
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 3
• 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 3
• 208000017604 Hodgkin disease Diseases 0.000 description 3
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 3
• 101000738354 Homo sapiens CD9 antigen Proteins 0.000 description 3
• 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 3
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 3
• 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 3
• 101001055145 Homo sapiens Interleukin-2 receptor subunit beta Proteins 0.000 description 3
• 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 description 3
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 3
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 3
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 3
• 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 description 3
• 108090000144 Human Proteins Proteins 0.000 description 3
• 102000003839 Human Proteins Human genes 0.000 description 3
• 241000701806 Human papillomavirus Species 0.000 description 3
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 3
• 208000005016 Intestinal Neoplasms Diseases 0.000 description 3
• 208000008839 Kidney Neoplasms Diseases 0.000 description 3
• 102100031586 Leukocyte antigen CD37 Human genes 0.000 description 3
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 3
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
• 201000005505 Measles Diseases 0.000 description 3
• 208000003445 Mouth Neoplasms Diseases 0.000 description 3
• 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 3
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 3
• 102100023832 Prolyl endopeptidase FAP Human genes 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 206010060862 Prostate cancer Diseases 0.000 description 3
• 108010072866 Prostate-Specific Antigen Proteins 0.000 description 3
• 102100038358 Prostate-specific antigen Human genes 0.000 description 3
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 3
• 101710188315 Protein X Proteins 0.000 description 3
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 3
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 3
• 206010038389 Renal cancer Diseases 0.000 description 3
• 241000710961 Semliki Forest virus Species 0.000 description 3
• 208000005718 Stomach Neoplasms Diseases 0.000 description 3
• 101710097909 Substance-P receptor Proteins 0.000 description 3
• 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 description 3
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 3
• 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 description 3
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 3
• 239000004480 active ingredient Substances 0.000 description 3
• 102000013529 alpha-Fetoproteins Human genes 0.000 description 3
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 201000010881 cervical cancer Diseases 0.000 description 3
• 208000006990 cholangiocarcinoma Diseases 0.000 description 3
• 230000004069 differentiation Effects 0.000 description 3
• 239000002552 dosage form Substances 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 235000019152 folic acid Nutrition 0.000 description 3
• 108020001507 fusion proteins Proteins 0.000 description 3
• 102000037865 fusion proteins Human genes 0.000 description 3
• 230000001506 immunosuppresive effect Effects 0.000 description 3
• 238000001802 infusion Methods 0.000 description 3
• 210000004964 innate lymphoid cell Anatomy 0.000 description 3
• 201000002313 intestinal cancer Diseases 0.000 description 3
• 230000010262 intracellular communication Effects 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 201000010982 kidney cancer Diseases 0.000 description 3
• 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 3
• 201000005202 lung cancer Diseases 0.000 description 3
• 208000020816 lung neoplasm Diseases 0.000 description 3
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 3
• 201000001441 melanoma Diseases 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• 201000002528 pancreatic cancer Diseases 0.000 description 3
• 208000008443 pancreatic carcinoma Diseases 0.000 description 3
• 229920001481 poly(stearyl methacrylate) Polymers 0.000 description 3
• 239000003755 preservative agent Substances 0.000 description 3
• 150000003384 small molecules Chemical class 0.000 description 3
• 201000011096 spinal cancer Diseases 0.000 description 3
• 208000014618 spinal cord cancer Diseases 0.000 description 3
• 239000003381 stabilizer Substances 0.000 description 3
• 201000011549 stomach cancer Diseases 0.000 description 3
• 238000007920 subcutaneous administration Methods 0.000 description 3
• 230000002194 synthesizing effect Effects 0.000 description 3
• 210000001519 tissue Anatomy 0.000 description 3
• 102000035160 transmembrane proteins Human genes 0.000 description 3
• 108091005703 transmembrane proteins Proteins 0.000 description 3
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
• JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 2
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 2
• LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 2
• WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 description 2
• 108020003589 5' Untranslated Regions Proteins 0.000 description 2
• 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 2
• 241001664176 Alpharetrovirus Species 0.000 description 2
• 206010003571 Astrocytoma Diseases 0.000 description 2
• 108010029697 CD40 Ligand Proteins 0.000 description 2
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 2
• 241000711969 Chandipura virus Species 0.000 description 2
• 108091007741 Chimeric antigen receptor T cells Proteins 0.000 description 2
• 208000005243 Chondrosarcoma Diseases 0.000 description 2
• 108010068682 Cyclophilins Proteins 0.000 description 2
• 102000001493 Cyclophilins Human genes 0.000 description 2
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
• 229930105110 Cyclosporin A Natural products 0.000 description 2
• 108010036949 Cyclosporine Proteins 0.000 description 2
• 108010025905 Cystine-Knot Miniproteins Proteins 0.000 description 2
• 108700022150 Designed Ankyrin Repeat Proteins Proteins 0.000 description 2
• 206010014733 Endometrial cancer Diseases 0.000 description 2
• 206010014759 Endometrial neoplasm Diseases 0.000 description 2
• 206010066919 Epidemic polyarthritis Diseases 0.000 description 2
• 241000714165 Feline leukemia virus Species 0.000 description 2
• 241000714475 Fujinami sarcoma virus Species 0.000 description 2
• 102100021197 G-protein coupled receptor family C group 5 member D Human genes 0.000 description 2
• 241001663880 Gammaretrovirus Species 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 108060003393 Granulin Proteins 0.000 description 2
• 208000031886 HIV Infections Diseases 0.000 description 2
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 2
• 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 2
• 101000954709 Homo sapiens Doublecortin domain-containing protein 2 Proteins 0.000 description 2
• 101001040713 Homo sapiens G-protein coupled receptor family C group 5 member D Proteins 0.000 description 2
• 101000985516 Homo sapiens Hermansky-Pudlak syndrome 5 protein Proteins 0.000 description 2
• 101000614481 Homo sapiens Kidney-associated antigen 1 Proteins 0.000 description 2
• 101000608935 Homo sapiens Leukosialin Proteins 0.000 description 2
• 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 2
• 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 2
• 101001062093 Homo sapiens RNA-binding protein 15 Proteins 0.000 description 2
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
• 101000973629 Homo sapiens Ribosome quality control complex subunit NEMF Proteins 0.000 description 2
• 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 description 2
• 101000665137 Homo sapiens Scm-like with four MBT domains protein 1 Proteins 0.000 description 2
• 101001001300 Human cytomegalovirus (strain Towne) 65 kDa phosphoprotein Proteins 0.000 description 2
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 2
• 102100034353 Integrase Human genes 0.000 description 2
• 108090000172 Interleukin-15 Proteins 0.000 description 2
• 102000003812 Interleukin-15 Human genes 0.000 description 2
• 108010017411 Interleukin-21 Receptors Proteins 0.000 description 2
• 102100030699 Interleukin-21 receptor Human genes 0.000 description 2
• 108090001005 Interleukin-6 Proteins 0.000 description 2
• 102000004889 Interleukin-6 Human genes 0.000 description 2
• 102100021592 Interleukin-7 Human genes 0.000 description 2
• 108010002586 Interleukin-7 Proteins 0.000 description 2
• 108010038498 Interleukin-7 Receptors Proteins 0.000 description 2
• 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 description 2
• 102100031413 L-dopachrome tautomerase Human genes 0.000 description 2
• 101710093778 L-dopachrome tautomerase Proteins 0.000 description 2
• 208000032420 Latent Infection Diseases 0.000 description 2
• 102100039564 Leukosialin Human genes 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 102000018697 Membrane Proteins Human genes 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 201000009906 Meningitis Diseases 0.000 description 2
• 241000713869 Moloney murine leukemia virus Species 0.000 description 2
• 241000713862 Moloney murine sarcoma virus Species 0.000 description 2
• 102100034256 Mucin-1 Human genes 0.000 description 2
• 208000034578 Multiple myelomas Diseases 0.000 description 2
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 2
• 102100029527 Natural cytotoxicity triggering receptor 3 ligand 1 Human genes 0.000 description 2
• 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 description 2
• 101800000399 Neurokinin A Proteins 0.000 description 2
• 206010061336 Pelvic neoplasm Diseases 0.000 description 2
• 206010035226 Plasma cell myeloma Diseases 0.000 description 2
• 102100029244 RNA-binding protein 15 Human genes 0.000 description 2
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 102100022213 Ribosome quality control complex subunit NEMF Human genes 0.000 description 2
• 241000710942 Ross River virus Species 0.000 description 2
• 241000714474 Rous sarcoma virus Species 0.000 description 2
• 101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 2
• 206010041067 Small cell lung cancer Diseases 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 208000021712 Soft tissue sarcoma Diseases 0.000 description 2
• 101800003906 Substance P Proteins 0.000 description 2
• 208000002847 Surgical Wound Diseases 0.000 description 2
• 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 2
• 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 2
• 108091036066 Three prime untranslated region Proteins 0.000 description 2
• 108010022394 Threonine synthase Proteins 0.000 description 2
• 108700019146 Transgenes Proteins 0.000 description 2
• 102000003425 Tyrosinase Human genes 0.000 description 2
• 108060008724 Tyrosinase Proteins 0.000 description 2
• 229940127174 UCHT1 Drugs 0.000 description 2
• 239000012190 activator Substances 0.000 description 2
• 208000009956 adenocarcinoma Diseases 0.000 description 2
• 125000003277 amino group Chemical group 0.000 description 2
• 125000004429 atom Chemical group 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 208000026900 bile duct neoplasm Diseases 0.000 description 2
• 229960003008 blinatumomab Drugs 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 125000004432 carbon atom Chemical group C* 0.000 description 2
• 208000002458 carcinoid tumor Diseases 0.000 description 2
• 230000004663 cell proliferation Effects 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 210000004748 cultured cell Anatomy 0.000 description 2
• 210000000448 cultured tumor cell Anatomy 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 102000004419 dihydrofolate reductase Human genes 0.000 description 2
• 208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 238000004520 electroporation Methods 0.000 description 2
• 108010078428 env Gene Products Proteins 0.000 description 2
• 208000024519 eye neoplasm Diseases 0.000 description 2
• 102000006815 folate receptor Human genes 0.000 description 2
• 108020005243 folate receptor Proteins 0.000 description 2
• 229960000304 folic acid Drugs 0.000 description 2
• 238000002825 functional assay Methods 0.000 description 2
• 206010017758 gastric cancer Diseases 0.000 description 2
• 230000002496 gastric effect Effects 0.000 description 2
• 238000001415 gene therapy Methods 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 201000010536 head and neck cancer Diseases 0.000 description 2
• 208000014829 head and neck neoplasm Diseases 0.000 description 2
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 208000037797 influenza A Diseases 0.000 description 2
• 208000037798 influenza B Diseases 0.000 description 2
• 208000037799 influenza C Diseases 0.000 description 2
• 208000037800 influenza D Diseases 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 229940047122 interleukins Drugs 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• ZBKFYXZXZJPWNQ-UHFFFAOYSA-N isothiocyanate group Chemical group [N-]=C=S ZBKFYXZXZJPWNQ-UHFFFAOYSA-N 0.000 description 2
• 201000007270 liver cancer Diseases 0.000 description 2
• 208000014018 liver neoplasm Diseases 0.000 description 2
• 210000001165 lymph node Anatomy 0.000 description 2
• 230000000527 lymphocytic effect Effects 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 230000001404 mediated effect Effects 0.000 description 2
• 238000009126 molecular therapy Methods 0.000 description 2
• 229960003816 muromonab-cd3 Drugs 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
• 201000008106 ocular cancer Diseases 0.000 description 2
• OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
• 238000010839 reverse transcription Methods 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 101150047061 tag-72 gene Proteins 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• 108010078373 tisagenlecleucel Proteins 0.000 description 2
• 238000004448 titration Methods 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
• 241000701447 unidentified baculovirus Species 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• VQTBINYMFPKLQD-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-(3-hydroxy-6-oxoxanthen-9-yl)benzoate Chemical compound C=12C=CC(=O)C=C2OC2=CC(O)=CC=C2C=1C1=CC=CC=C1C(=O)ON1C(=O)CCC1=O VQTBINYMFPKLQD-UHFFFAOYSA-N 0.000 description 1
• HEAUFJZALFKPBA-JPQUDPSNSA-N (3s)-3-[[(2s,3r)-2-[[(2s)-6-amino-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-4-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[2-[[(2s)-1-[[(2s)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amin Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 HEAUFJZALFKPBA-JPQUDPSNSA-N 0.000 description 1
• UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
• 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
• 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
• 101710163573 5-hydroxyisourate hydrolase Proteins 0.000 description 1
• 102100040079 A-kinase anchor protein 4 Human genes 0.000 description 1
• 101710109924 A-kinase anchor protein 4 Proteins 0.000 description 1
• 102000017918 ADRB3 Human genes 0.000 description 1
• 108060003355 ADRB3 Proteins 0.000 description 1
• 102100033793 ALK tyrosine kinase receptor Human genes 0.000 description 1
• 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 1
• 229940124661 Abecma Drugs 0.000 description 1
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
• 102100026423 Adhesion G protein-coupled receptor E5 Human genes 0.000 description 1
• 206010061424 Anal cancer Diseases 0.000 description 1
• 102100032187 Androgen receptor Human genes 0.000 description 1
• 201000003076 Angiosarcoma Diseases 0.000 description 1
• 102100023003 Ankyrin repeat domain-containing protein 30A Human genes 0.000 description 1
• 101710145634 Antigen 1 Proteins 0.000 description 1
• 208000007860 Anus Neoplasms Diseases 0.000 description 1
• 101001005269 Arabidopsis thaliana Ceramide synthase 1 LOH3 Proteins 0.000 description 1
• 101001005312 Arabidopsis thaliana Ceramide synthase LOH1 Proteins 0.000 description 1
• 101100067974 Arabidopsis thaliana POP2 gene Proteins 0.000 description 1
• 102100024003 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 Human genes 0.000 description 1
• 108010031480 Artificial Receptors Proteins 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 241000713840 Avian erythroblastosis virus Species 0.000 description 1
• 102100035526 B melanoma antigen 1 Human genes 0.000 description 1
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
• 208000003950 B-cell lymphoma Diseases 0.000 description 1
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
• 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 description 1
• 102100027522 Baculoviral IAP repeat-containing protein 7 Human genes 0.000 description 1
• 206010004146 Basal cell carcinoma Diseases 0.000 description 1
• 102000015735 Beta-catenin Human genes 0.000 description 1
• 108060000903 Beta-catenin Proteins 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 206010005949 Bone cancer Diseases 0.000 description 1
• 208000018084 Bone neoplasm Diseases 0.000 description 1
• 206010055113 Breast cancer metastatic Diseases 0.000 description 1
• 102100026094 C-type lectin domain family 12 member A Human genes 0.000 description 1
• 101710188619 C-type lectin domain family 12 member A Proteins 0.000 description 1
• 102100038078 CD276 antigen Human genes 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• 108010058905 CD44v6 antigen Proteins 0.000 description 1
• 102100025221 CD70 antigen Human genes 0.000 description 1
• 102000004631 Calcineurin Human genes 0.000 description 1
• 108010042955 Calcineurin Proteins 0.000 description 1
• 102100028801 Calsyntenin-1 Human genes 0.000 description 1
• 241000282836 Camelus dromedarius Species 0.000 description 1
• 102100025570 Cancer/testis antigen 1 Human genes 0.000 description 1
• 102100039510 Cancer/testis antigen 2 Human genes 0.000 description 1
• 102000013392 Carboxylesterase Human genes 0.000 description 1
• 108010051152 Carboxylesterase Proteins 0.000 description 1
• 102000012406 Carcinoembryonic Antigen Human genes 0.000 description 1
• 206010007275 Carcinoid tumour Diseases 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 101710178046 Chorismate synthase 1 Proteins 0.000 description 1
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
• 102100038449 Claudin-6 Human genes 0.000 description 1
• 101000996951 Cocal virus Glycoprotein Proteins 0.000 description 1
• 102100035167 Coiled-coil domain-containing protein 54 Human genes 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 102100030886 Complement receptor type 1 Human genes 0.000 description 1
• 208000009798 Craniopharyngioma Diseases 0.000 description 1
• 108010060385 Cyclin B1 Proteins 0.000 description 1
• 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 1
• 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 description 1
• 108010072220 Cyclophilin A Proteins 0.000 description 1
• 108010072210 Cyclophilin C Proteins 0.000 description 1
• 101710152695 Cysteine synthase 1 Proteins 0.000 description 1
• 101100481408 Danio rerio tie2 gene Proteins 0.000 description 1
• 206010011968 Decreased immune responsiveness Diseases 0.000 description 1
• 208000021994 Diffuse astrocytoma Diseases 0.000 description 1
• SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
• 102000001301 EGF receptor Human genes 0.000 description 1
• 102000012804 EPCAM Human genes 0.000 description 1
• 101150084967 EPCAM gene Proteins 0.000 description 1
• 101150029707 ERBB2 gene Proteins 0.000 description 1
• 102100038083 Endosialin Human genes 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 206010014967 Ependymoma Diseases 0.000 description 1
• 108010055196 EphA2 Receptor Proteins 0.000 description 1
• 102100030340 Ephrin type-A receptor 2 Human genes 0.000 description 1
• 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 1
• 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 1
• 201000005231 Epithelioid sarcoma Diseases 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• 208000006168 Ewing Sarcoma Diseases 0.000 description 1
• 241000713859 FBR murine osteosarcoma virus Species 0.000 description 1
• 201000001342 Fallopian tube cancer Diseases 0.000 description 1
• 208000013452 Fallopian tube neoplasm Diseases 0.000 description 1
• 102100031507 Fc receptor-like protein 5 Human genes 0.000 description 1
• 108010087819 Fc receptors Proteins 0.000 description 1
• 102000009109 Fc receptors Human genes 0.000 description 1
• 101150032879 Fcrl5 gene Proteins 0.000 description 1
• 108010003471 Fetal Proteins Proteins 0.000 description 1
• 102000004641 Fetal Proteins Human genes 0.000 description 1
• 102100028073 Fibroblast growth factor 5 Human genes 0.000 description 1
• 108090000380 Fibroblast growth factor 5 Proteins 0.000 description 1
• 201000008808 Fibrosarcoma Diseases 0.000 description 1
• 102000010449 Folate receptor beta Human genes 0.000 description 1
• 108050001930 Folate receptor beta Proteins 0.000 description 1
• 102000003817 Fos-related antigen 1 Human genes 0.000 description 1
• 108090000123 Fos-related antigen 1 Proteins 0.000 description 1
• 102100039717 G antigen 1 Human genes 0.000 description 1
• 102100036939 G-protein coupled receptor 20 Human genes 0.000 description 1
• 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 description 1
• 101710113436 GTPase KRas Proteins 0.000 description 1
• 102100040510 Galectin-3-binding protein Human genes 0.000 description 1
• 101710197901 Galectin-3-binding protein Proteins 0.000 description 1
• 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
• 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
• 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
• 208000031852 Gastrointestinal stromal cancer Diseases 0.000 description 1
• 206010051066 Gastrointestinal stromal tumour Diseases 0.000 description 1
• 208000034951 Genetic Translocation Diseases 0.000 description 1
• 208000021309 Germ cell tumor Diseases 0.000 description 1
• 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 102100032530 Glypican-3 Human genes 0.000 description 1
• 102100035943 HERV-H LTR-associating protein 2 Human genes 0.000 description 1
• 208000002125 Hemangioendothelioma Diseases 0.000 description 1
• 208000001258 Hemangiosarcoma Diseases 0.000 description 1
• 108010007712 Hepatitis A Virus Cellular Receptor 1 Proteins 0.000 description 1
• 102100034459 Hepatitis A virus cellular receptor 1 Human genes 0.000 description 1
• 102100028721 Hermansky-Pudlak syndrome 5 protein Human genes 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000779641 Homo sapiens ALK tyrosine kinase receptor Proteins 0.000 description 1
• 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 1
• 101000718243 Homo sapiens Adhesion G protein-coupled receptor E5 Proteins 0.000 description 1
• 101000757191 Homo sapiens Ankyrin repeat domain-containing protein 30A Proteins 0.000 description 1
• 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 description 1
• 101000936083 Homo sapiens Baculoviral IAP repeat-containing protein 7 Proteins 0.000 description 1
• 101100165850 Homo sapiens CA9 gene Proteins 0.000 description 1
• 101100383038 Homo sapiens CD19 gene Proteins 0.000 description 1
• 101000884279 Homo sapiens CD276 antigen Proteins 0.000 description 1
• 101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 1
• 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 1
• 101000889345 Homo sapiens Cancer/testis antigen 2 Proteins 0.000 description 1
• 101000882898 Homo sapiens Claudin-6 Proteins 0.000 description 1
• 101000737052 Homo sapiens Coiled-coil domain-containing protein 54 Proteins 0.000 description 1
• 101000727061 Homo sapiens Complement receptor type 1 Proteins 0.000 description 1
• 101100118549 Homo sapiens EGFR gene Proteins 0.000 description 1
• 101000884275 Homo sapiens Endosialin Proteins 0.000 description 1
• 101000886137 Homo sapiens G antigen 1 Proteins 0.000 description 1
• 101001071355 Homo sapiens G-protein coupled receptor 20 Proteins 0.000 description 1
• 101001014668 Homo sapiens Glypican-3 Proteins 0.000 description 1
• 101001021491 Homo sapiens HERV-H LTR-associating protein 2 Proteins 0.000 description 1
• 101001019455 Homo sapiens ICOS ligand Proteins 0.000 description 1
• 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 description 1
• 101001003135 Homo sapiens Interleukin-13 receptor subunit alpha-1 Proteins 0.000 description 1
• 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 description 1
• 101001051093 Homo sapiens Low-density lipoprotein receptor Proteins 0.000 description 1
• 101001065550 Homo sapiens Lymphocyte antigen 6K Proteins 0.000 description 1
• 101001014223 Homo sapiens MAPK/MAK/MRK overlapping kinase Proteins 0.000 description 1
• 101000991061 Homo sapiens MHC class I polypeptide-related sequence B Proteins 0.000 description 1
• 101100495232 Homo sapiens MS4A1 gene Proteins 0.000 description 1
• 101000934372 Homo sapiens Macrosialin Proteins 0.000 description 1
• 101000623901 Homo sapiens Mucin-16 Proteins 0.000 description 1
• 101100460850 Homo sapiens NCR3LG1 gene Proteins 0.000 description 1
• 101001109503 Homo sapiens NKG2-C type II integral membrane protein Proteins 0.000 description 1
• 101001051490 Homo sapiens Neural cell adhesion molecule L1 Proteins 0.000 description 1
• 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 description 1
• 101000721757 Homo sapiens Olfactory receptor 51E2 Proteins 0.000 description 1
• 101000613490 Homo sapiens Paired box protein Pax-3 Proteins 0.000 description 1
• 101000589399 Homo sapiens Pannexin-3 Proteins 0.000 description 1
• 101000691463 Homo sapiens Placenta-specific protein 1 Proteins 0.000 description 1
• 101001064779 Homo sapiens Plexin domain-containing protein 2 Proteins 0.000 description 1
• 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 description 1
• 101001136981 Homo sapiens Proteasome subunit beta type-9 Proteins 0.000 description 1
• 101000880770 Homo sapiens Protein SSX2 Proteins 0.000 description 1
• 101100101727 Homo sapiens RAET1L gene Proteins 0.000 description 1
• 101001062222 Homo sapiens Receptor-binding cancer antigen expressed on SiSo cells Proteins 0.000 description 1
• 101001132524 Homo sapiens Retinoic acid early transcript 1E Proteins 0.000 description 1
• 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
• 101000824971 Homo sapiens Sperm surface protein Sp17 Proteins 0.000 description 1
• 101000873927 Homo sapiens Squamous cell carcinoma antigen recognized by T-cells 3 Proteins 0.000 description 1
• 101100207070 Homo sapiens TNFSF8 gene Proteins 0.000 description 1
• 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 description 1
• 101000847107 Homo sapiens Tetraspanin-8 Proteins 0.000 description 1
• 101000772267 Homo sapiens Thyrotropin receptor Proteins 0.000 description 1
• 101000638154 Homo sapiens Transmembrane protease serine 2 Proteins 0.000 description 1
• 101001047681 Homo sapiens Tyrosine-protein kinase Lck Proteins 0.000 description 1
• 101000607316 Homo sapiens UL-16 binding protein 5 Proteins 0.000 description 1
• 101000607306 Homo sapiens UL16-binding protein 1 Proteins 0.000 description 1
• 101000607320 Homo sapiens UL16-binding protein 2 Proteins 0.000 description 1
• 101000607318 Homo sapiens UL16-binding protein 3 Proteins 0.000 description 1
• 101000808105 Homo sapiens Uroplakin-2 Proteins 0.000 description 1
• 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 1
• 101000814512 Homo sapiens X antigen family member 1 Proteins 0.000 description 1
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
• 241000714192 Human spumaretrovirus Species 0.000 description 1
• 108010003272 Hyaluronate lyase Proteins 0.000 description 1
• 102000001974 Hyaluronidases Human genes 0.000 description 1
• 102000004157 Hydrolases Human genes 0.000 description 1
• 108090000604 Hydrolases Proteins 0.000 description 1
• 108010052919 Hydroxyethylthiazole kinase Proteins 0.000 description 1
• 108010027436 Hydroxymethylpyrimidine kinase Proteins 0.000 description 1
• 206010021042 Hypopharyngeal cancer Diseases 0.000 description 1
• 206010056305 Hypopharyngeal neoplasm Diseases 0.000 description 1
• 102100034980 ICOS ligand Human genes 0.000 description 1
• 108010031794 IGF Type 1 Receptor Proteins 0.000 description 1
• 108700012441 IGF2 Proteins 0.000 description 1
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
• 206010062016 Immunosuppression Diseases 0.000 description 1
• 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 208000005726 Inflammatory Breast Neoplasms Diseases 0.000 description 1
• 206010021980 Inflammatory carcinoma of the breast Diseases 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 1
• 108010030506 Integrin alpha6beta4 Proteins 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102000013462 Interleukin-12 Human genes 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 102100020791 Interleukin-13 receptor subunit alpha-1 Human genes 0.000 description 1
• 102000003810 Interleukin-18 Human genes 0.000 description 1
• 108090000171 Interleukin-18 Proteins 0.000 description 1
• 102100030704 Interleukin-21 Human genes 0.000 description 1
• 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 description 1
• 208000037396 Intraductal Noninfiltrating Carcinoma Diseases 0.000 description 1
• 206010073094 Intraductal proliferative breast lesion Diseases 0.000 description 1
• 108020003285 Isocitrate lyase Proteins 0.000 description 1
• 230000004163 JAK-STAT signaling pathway Effects 0.000 description 1
• 208000009147 Jaw Neoplasms Diseases 0.000 description 1
• 208000007766 Kaposi sarcoma Diseases 0.000 description 1
• 101150113776 LMP1 gene Proteins 0.000 description 1
• 206010023825 Laryngeal cancer Diseases 0.000 description 1
• 208000018142 Leiomyosarcoma Diseases 0.000 description 1
• 206010062038 Lip neoplasm Diseases 0.000 description 1
• 206010073099 Lobular breast carcinoma in situ Diseases 0.000 description 1
• 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
• 102100032129 Lymphocyte antigen 6K Human genes 0.000 description 1
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
• 102100031520 MAPK/MAK/MRK overlapping kinase Human genes 0.000 description 1
• 102000016200 MART-1 Antigen Human genes 0.000 description 1
• 108010010995 MART-1 Antigen Proteins 0.000 description 1
• 102100030301 MHC class I polypeptide-related sequence A Human genes 0.000 description 1
• 102100030300 MHC class I polypeptide-related sequence B Human genes 0.000 description 1
• 108700012912 MYCN Proteins 0.000 description 1
• 101150022024 MYCN gene Proteins 0.000 description 1
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
• 102100025136 Macrosialin Human genes 0.000 description 1
• 208000004059 Male Breast Neoplasms Diseases 0.000 description 1
• 208000030070 Malignant epithelial tumor of ovary Diseases 0.000 description 1
• 206010025997 Malignant neoplasm of islets of Langerhans Diseases 0.000 description 1
• 208000032271 Malignant tumor of penis Diseases 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 208000007054 Medullary Carcinoma Diseases 0.000 description 1
• 208000000172 Medulloblastoma Diseases 0.000 description 1
• 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
• 208000002030 Merkel cell carcinoma Diseases 0.000 description 1
• 201000009574 Mesenchymal Chondrosarcoma Diseases 0.000 description 1
• 108090000015 Mesothelin Proteins 0.000 description 1
• 102000003735 Mesothelin Human genes 0.000 description 1
• 206010027406 Mesothelioma Diseases 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 206010027480 Metastatic malignant melanoma Diseases 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 102100023123 Mucin-16 Human genes 0.000 description 1
• 241000699666 Mus <mouse, genus> Species 0.000 description 1
• 101100335081 Mus musculus Flt3 gene Proteins 0.000 description 1
• 101100481410 Mus musculus Tek gene Proteins 0.000 description 1
• 101100207071 Mus musculus Tnfsf8 gene Proteins 0.000 description 1
• 101000597780 Mus musculus Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 description 1
• 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
• 108700026495 N-Myc Proto-Oncogene Proteins 0.000 description 1
• OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
• 102100030124 N-myc proto-oncogene protein Human genes 0.000 description 1
• 230000006051 NK cell activation Effects 0.000 description 1
• 102100022683 NKG2-C type II integral membrane protein Human genes 0.000 description 1
• 206010028767 Nasal sinus cancer Diseases 0.000 description 1
• 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
• 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
• 108010077854 Natural Killer Cell Receptors Proteins 0.000 description 1
• 102000010648 Natural Killer Cell Receptors Human genes 0.000 description 1
• 101710201161 Natural cytotoxicity triggering receptor 3 ligand 1 Proteins 0.000 description 1
• 208000034176 Neoplasms, Germ Cell and Embryonal Diseases 0.000 description 1
• 108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 description 1
• 108010069196 Neural Cell Adhesion Molecules Proteins 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 206010029266 Neuroendocrine carcinoma of the skin Diseases 0.000 description 1
• 206010052399 Neuroendocrine tumour Diseases 0.000 description 1
• 102400000097 Neurokinin A Human genes 0.000 description 1
• HEAUFJZALFKPBA-YRVBCFNBSA-N Neurokinin A Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)O)C1=CC=CC=C1 HEAUFJZALFKPBA-YRVBCFNBSA-N 0.000 description 1
• 102000046798 Neurokinin B Human genes 0.000 description 1
• NHXYSAFTNPANFK-HDMCBQFHSA-N Neurokinin B Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(O)=O)C1=CC=CC=C1 NHXYSAFTNPANFK-HDMCBQFHSA-N 0.000 description 1
• 108010040718 Neurokinin-1 Receptors Proteins 0.000 description 1
• 101800002813 Neurokinin-B Proteins 0.000 description 1
• 101800000923 Neuropeptide K Proteins 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 208000010505 Nose Neoplasms Diseases 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 102100025128 Olfactory receptor 51E2 Human genes 0.000 description 1
• 201000010133 Oligodendroglioma Diseases 0.000 description 1
• 108700020796 Oncogene Proteins 0.000 description 1
• 102000043276 Oncogene Human genes 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 206010031096 Oropharyngeal cancer Diseases 0.000 description 1
• 206010057444 Oropharyngeal neoplasm Diseases 0.000 description 1
• 208000010191 Osteitis Deformans Diseases 0.000 description 1
• 101710160107 Outer membrane protein A Proteins 0.000 description 1
• 208000007571 Ovarian Epithelial Carcinoma Diseases 0.000 description 1
• 206010061328 Ovarian epithelial cancer Diseases 0.000 description 1
• 240000007019 Oxalis corniculata Species 0.000 description 1
• 208000027868 Paget disease Diseases 0.000 description 1
• 102100040891 Paired box protein Pax-3 Human genes 0.000 description 1
• 102100032364 Pannexin-3 Human genes 0.000 description 1
• 208000003937 Paranasal Sinus Neoplasms Diseases 0.000 description 1
• 208000000821 Parathyroid Neoplasms Diseases 0.000 description 1
• 208000002471 Penile Neoplasms Diseases 0.000 description 1
• 206010034299 Penile cancer Diseases 0.000 description 1
• 102100034539 Peptidyl-prolyl cis-trans isomerase A Human genes 0.000 description 1
• 102100024968 Peptidyl-prolyl cis-trans isomerase C Human genes 0.000 description 1
• 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
• 206010034811 Pharyngeal cancer Diseases 0.000 description 1
• 206010050487 Pinealoblastoma Diseases 0.000 description 1
• 241000711965 Piry virus Species 0.000 description 1
• 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
• 102100026181 Placenta-specific protein 1 Human genes 0.000 description 1
• 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 description 1
• 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 1
• 102100031889 Plexin domain-containing protein 2 Human genes 0.000 description 1
• 102100029740 Poliovirus receptor Human genes 0.000 description 1
• 229920000037 Polyproline Polymers 0.000 description 1
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
• 208000026149 Primary peritoneal carcinoma Diseases 0.000 description 1
• 102100036735 Prostate stem cell antigen Human genes 0.000 description 1
• 102100035764 Proteasome subunit beta type-9 Human genes 0.000 description 1
• 102100032831 Protein ITPRID2 Human genes 0.000 description 1
• 102100037686 Protein SSX2 Human genes 0.000 description 1
• 101000933967 Pseudomonas phage KPP25 Major capsid protein Proteins 0.000 description 1
• 101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
• 102100029165 Receptor-binding cancer antigen expressed on SiSo cells Human genes 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• 208000006265 Renal cell carcinoma Diseases 0.000 description 1
• 102100033964 Retinoic acid early transcript 1E Human genes 0.000 description 1
• 102100029198 SLAM family member 7 Human genes 0.000 description 1
• 101100123851 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HER1 gene Proteins 0.000 description 1
• 208000004337 Salivary Gland Neoplasms Diseases 0.000 description 1
• 206010061934 Salivary gland cancer Diseases 0.000 description 1
• 102100038689 Scm-like with four MBT domains protein 1 Human genes 0.000 description 1
• 101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 1
• 102100038081 Signal transducer CD24 Human genes 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 102100037253 Solute carrier family 45 member 3 Human genes 0.000 description 1
• 101000668858 Spinacia oleracea 30S ribosomal protein S1, chloroplastic Proteins 0.000 description 1
• 102100035748 Squamous cell carcinoma antigen recognized by T-cells 3 Human genes 0.000 description 1
• 101000898746 Streptomyces clavuligerus Clavaminate synthase 1 Proteins 0.000 description 1
• 108010002687 Survivin Proteins 0.000 description 1
• 230000006052 T cell proliferation Effects 0.000 description 1
• 208000000389 T-cell leukemia Diseases 0.000 description 1
• 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
• 101710165202 T-cell surface antigen CD2 Proteins 0.000 description 1
• 101150057140 TACSTD1 gene Proteins 0.000 description 1
• 101150031162 TM4SF1 gene Proteins 0.000 description 1
• 102000003141 Tachykinin Human genes 0.000 description 1
• 108010072901 Tachykinin Receptors Proteins 0.000 description 1
• 102000007124 Tachykinin Receptors Human genes 0.000 description 1
• QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
• 108010017842 Telomerase Proteins 0.000 description 1
• 102100032802 Tetraspanin-8 Human genes 0.000 description 1
• 108010034949 Thyroglobulin Proteins 0.000 description 1
• 102000009843 Thyroglobulin Human genes 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• 102100029337 Thyrotropin receptor Human genes 0.000 description 1
• 102100034902 Transmembrane 4 L6 family member 1 Human genes 0.000 description 1
• 102100031989 Transmembrane protease serine 2 Human genes 0.000 description 1
• LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 1
• 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
• 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
• 102100035283 Tumor necrosis factor ligand superfamily member 18 Human genes 0.000 description 1
• 102100032100 Tumor necrosis factor ligand superfamily member 8 Human genes 0.000 description 1
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 1
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
• 102100024036 Tyrosine-protein kinase Lck Human genes 0.000 description 1
• 102100040010 UL-16 binding protein 5 Human genes 0.000 description 1
• 102100040012 UL16-binding protein 1 Human genes 0.000 description 1
• 102100039989 UL16-binding protein 2 Human genes 0.000 description 1
• 102100040011 UL16-binding protein 3 Human genes 0.000 description 1
• 102100040013 UL16-binding protein 6 Human genes 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 102100038851 Uroplakin-2 Human genes 0.000 description 1
• 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 1
• 108700005077 Viral Genes Proteins 0.000 description 1
• 206010047741 Vulval cancer Diseases 0.000 description 1
• 208000004354 Vulvar Neoplasms Diseases 0.000 description 1
• 102100039490 X antigen family member 1 Human genes 0.000 description 1
• GQLCLPLEEOUJQC-ZTQDTCGGSA-N [(1r)-3-(3,4-dimethoxyphenyl)-1-[3-[2-[2-[[2-[3-[(1r)-3-(3,4-dimethoxyphenyl)-1-[(2s)-1-[(2s)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carbonyl]oxypropyl]phenoxy]acetyl]amino]ethylamino]-2-oxoethoxy]phenyl]propyl] (2s)-1-[(2s)-2-(3,4,5-trimethoxyph Chemical compound C([C@@H](OC(=O)[C@@H]1CCCCN1C(=O)[C@@H](CC)C=1C=C(OC)C(OC)=C(OC)C=1)C=1C=C(OCC(=O)NCCNC(=O)COC=2C=C(C=CC=2)[C@@H](CCC=2C=C(OC)C(OC)=CC=2)OC(=O)[C@H]2N(CCCC2)C(=O)[C@@H](CC)C=2C=C(OC)C(OC)=C(OC)C=2)C=CC=1)CC1=CC=C(OC)C(OC)=C1 GQLCLPLEEOUJQC-ZTQDTCGGSA-N 0.000 description 1
• WTIJXIZOODAMJT-WBACWINTSA-N [(3r,4s,5r,6s)-5-hydroxy-6-[4-hydroxy-3-[[5-[[4-hydroxy-7-[(2s,3r,4s,5r)-3-hydroxy-5-methoxy-6,6-dimethyl-4-(5-methyl-1h-pyrrole-2-carbonyl)oxyoxan-2-yl]oxy-8-methyl-2-oxochromen-3-yl]carbamoyl]-4-methyl-1h-pyrrole-3-carbonyl]amino]-8-methyl-2-oxochromen- Chemical compound O([C@@H]1[C@H](C(O[C@H](OC=2C(=C3OC(=O)C(NC(=O)C=4C(=C(C(=O)NC=5C(OC6=C(C)C(O[C@@H]7[C@@H]([C@H](OC(=O)C=8NC(C)=CC=8)[C@@H](OC)C(C)(C)O7)O)=CC=C6C=5O)=O)NC=4)C)=C(O)C3=CC=2)C)[C@@H]1O)(C)C)OC)C(=O)C1=CC=C(C)N1 WTIJXIZOODAMJT-WBACWINTSA-N 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 239000011149 active material Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 201000001256 adenosarcoma Diseases 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000001070 adhesive effect Effects 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 230000001919 adrenal effect Effects 0.000 description 1
• 201000005188 adrenal gland cancer Diseases 0.000 description 1
• 208000024447 adrenal gland neoplasm Diseases 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 102000002287 alpha Subunit Glycoprotein Hormones Human genes 0.000 description 1
• 108010000732 alpha Subunit Glycoprotein Hormones Proteins 0.000 description 1
• 239000003708 ampul Substances 0.000 description 1
• 206010002224 anaplastic astrocytoma Diseases 0.000 description 1
• 108010080146 androgen receptors Proteins 0.000 description 1
• 229940121363 anti-inflammatory agent Drugs 0.000 description 1
• 239000002260 anti-inflammatory agent Substances 0.000 description 1
• 230000001139 anti-pruritic effect Effects 0.000 description 1
• 230000000890 antigenic effect Effects 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 239000003908 antipruritic agent Substances 0.000 description 1
• 201000011165 anus cancer Diseases 0.000 description 1
• 239000008135 aqueous vehicle Substances 0.000 description 1
• 210000004507 artificial chromosome Anatomy 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 239000003212 astringent agent Substances 0.000 description 1
• 230000003140 astrocytic effect Effects 0.000 description 1
• 239000012752 auxiliary agent Substances 0.000 description 1
• 229950009579 axicabtagene ciloleucel Drugs 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 230000002457 bidirectional effect Effects 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 201000006491 bone marrow cancer Diseases 0.000 description 1
• 206010006007 bone sarcoma Diseases 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 210000000133 brain stem Anatomy 0.000 description 1
• 201000005389 breast carcinoma in situ Diseases 0.000 description 1
• 229940125163 brexucabtagene autoleucel Drugs 0.000 description 1
• 108010044481 calcineurin phosphatase Proteins 0.000 description 1
• 210000000234 capsid Anatomy 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 230000020411 cell activation Effects 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000019522 cellular metabolic process Effects 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 201000006612 cervical squamous cell carcinoma Diseases 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
• 229940054315 ciltacabtagene autoleucel Drugs 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 230000004186 co-expression Effects 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 230000001054 cortical effect Effects 0.000 description 1
• 108091008034 costimulatory receptors Proteins 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 208000030381 cutaneous melanoma Diseases 0.000 description 1
• 208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 description 1
• 230000016396 cytokine production Effects 0.000 description 1
• 230000001461 cytolytic effect Effects 0.000 description 1
• 210000000172 cytosol Anatomy 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
• SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 239000003814 drug Substances 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 208000028715 ductal breast carcinoma in situ Diseases 0.000 description 1
• 201000007273 ductal carcinoma in situ Diseases 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 239000006274 endogenous ligand Substances 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 229940088598 enzyme Drugs 0.000 description 1
• 108010087914 epidermal growth factor receptor VIII Proteins 0.000 description 1
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 201000008819 extrahepatic bile duct carcinoma Diseases 0.000 description 1
• 201000001169 fibrillary astrocytoma Diseases 0.000 description 1
• 210000000285 follicular dendritic cell Anatomy 0.000 description 1
• 125000002446 fucosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)[C@@H](O1)C)* 0.000 description 1
• 201000010175 gallbladder cancer Diseases 0.000 description 1
• 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
• 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
• 208000003884 gestational trophoblastic disease Diseases 0.000 description 1
• 208000005017 glioblastoma Diseases 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 210000003714 granulocyte Anatomy 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 210000002768 hair cell Anatomy 0.000 description 1
• 238000003306 harvesting Methods 0.000 description 1
• 201000005787 hematologic cancer Diseases 0.000 description 1
• 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
• 238000005734 heterodimerization reaction Methods 0.000 description 1
• 230000003284 homeostatic effect Effects 0.000 description 1
• 229940084986 human chorionic gonadotropin Drugs 0.000 description 1
• 229960002773 hyaluronidase Drugs 0.000 description 1
• 201000006866 hypopharynx cancer Diseases 0.000 description 1
• 108700004894 idecabtagene vicleucel Proteins 0.000 description 1
• 229940121453 idecabtagene vicleucel Drugs 0.000 description 1
• 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
• 239000012642 immune effector Substances 0.000 description 1
• 229940121354 immunomodulator Drugs 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 201000004653 inflammatory breast carcinoma Diseases 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 239000007972 injectable composition Substances 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 108010074108 interleukin-21 Proteins 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 238000007917 intracranial administration Methods 0.000 description 1
• 201000007450 intrahepatic cholangiocarcinoma Diseases 0.000 description 1
• 239000007928 intraperitoneal injection Substances 0.000 description 1
• 238000007919 intrasynovial administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 230000002601 intratumoral effect Effects 0.000 description 1
• 238000007915 intraurethral administration Methods 0.000 description 1
• 238000007914 intraventricular administration Methods 0.000 description 1
• 208000030776 invasive breast carcinoma Diseases 0.000 description 1
• 206010073095 invasive ductal breast carcinoma Diseases 0.000 description 1
• 201000010985 invasive ductal carcinoma Diseases 0.000 description 1
• 206010073096 invasive lobular breast carcinoma Diseases 0.000 description 1
• 201000001837 jaw cancer Diseases 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 229940045426 kymriah Drugs 0.000 description 1
• 206010023841 laryngeal neoplasm Diseases 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 201000006721 lip cancer Diseases 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 206010024627 liposarcoma Diseases 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 229940121459 lisocabtagene maraleucel Drugs 0.000 description 1
• 201000011059 lobular neoplasia Diseases 0.000 description 1
• 239000003589 local anesthetic agent Substances 0.000 description 1
• 229960005015 local anesthetics Drugs 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 208000022080 low-grade astrocytoma Diseases 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 201000000966 lung oat cell carcinoma Diseases 0.000 description 1
• 201000010453 lymph node cancer Diseases 0.000 description 1
• 201000003175 male breast cancer Diseases 0.000 description 1
• 208000010907 male breast carcinoma Diseases 0.000 description 1
• 208000026045 malignant tumor of parathyroid gland Diseases 0.000 description 1
• 208000027202 mammary Paget disease Diseases 0.000 description 1
• 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 1
• 206010027191 meningioma Diseases 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• 230000001394 metastastic effect Effects 0.000 description 1
• 208000021039 metastatic melanoma Diseases 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• 239000010445 mica Substances 0.000 description 1
• 229910052618 mica group Inorganic materials 0.000 description 1
• 238000012737 microarray-based gene expression Methods 0.000 description 1
• 239000003226 mitogen Substances 0.000 description 1
• 201000010879 mucinous adenocarcinoma Diseases 0.000 description 1
• 201000003731 mucosal melanoma Diseases 0.000 description 1
• 238000012243 multiplex automated genomic engineering Methods 0.000 description 1
• 201000005962 mycosis fungoides Diseases 0.000 description 1
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
• 208000037830 nasal cancer Diseases 0.000 description 1
• 208000016065 neuroendocrine neoplasm Diseases 0.000 description 1
• 201000011519 neuroendocrine tumor Diseases 0.000 description 1
• 210000000440 neutrophil Anatomy 0.000 description 1
• 239000012457 nonaqueous media Substances 0.000 description 1
• 229960003347 obinutuzumab Drugs 0.000 description 1
• 229950005751 ocrelizumab Drugs 0.000 description 1
• 201000002575 ocular melanoma Diseases 0.000 description 1
• 229940015719 odronextamab Drugs 0.000 description 1
• 229960002450 ofatumumab Drugs 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 201000006958 oropharynx cancer Diseases 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 230000002611 ovarian Effects 0.000 description 1
• 208000021284 ovarian germ cell tumor Diseases 0.000 description 1
• 201000006842 ovarian sex-cord stromal tumor Diseases 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 201000007052 paranasal sinus cancer Diseases 0.000 description 1
• 239000006072 paste Substances 0.000 description 1
• 238000000059 patterning Methods 0.000 description 1
• 230000000149 penetrating effect Effects 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 210000000578 peripheral nerve Anatomy 0.000 description 1
• 201000002628 peritoneum cancer Diseases 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 208000028591 pheochromocytoma Diseases 0.000 description 1
• 208000024724 pineal body neoplasm Diseases 0.000 description 1
• 208000010916 pituitary tumor Diseases 0.000 description 1
• 210000000557 podocyte Anatomy 0.000 description 1
• 108010048507 poliovirus receptor Proteins 0.000 description 1
• 229920001992 poloxamer 407 Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 108040000983 polyphosphate:AMP phosphotransferase activity proteins Proteins 0.000 description 1
• 108010026466 polyproline Proteins 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 230000003449 preventive effect Effects 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 239000000047 product Substances 0.000 description 1
• 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 108010079891 prostein Proteins 0.000 description 1
• 108010014186 ras Proteins Proteins 0.000 description 1
• 102000016914 ras Proteins Human genes 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 208000015347 renal cell adenocarcinoma Diseases 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 229960004641 rituximab Drugs 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 239000013605 shuttle vector Substances 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 208000037968 sinus cancer Diseases 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 201000003708 skin melanoma Diseases 0.000 description 1
• 208000000649 small cell carcinoma Diseases 0.000 description 1
• 208000000587 small cell lung carcinoma Diseases 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 208000037959 spinal tumor Diseases 0.000 description 1
• 206010041823 squamous cell carcinoma Diseases 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 230000000475 sunscreen effect Effects 0.000 description 1
• 239000000516 sunscreening agent Substances 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 210000000225 synapse Anatomy 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 108060008037 tachykinin Proteins 0.000 description 1
• QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 229960002175 thyroglobulin Drugs 0.000 description 1
• 201000002510 thyroid cancer Diseases 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 229950007137 tisagenlecleucel Drugs 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 108010020589 trehalose-6-phosphate synthase Proteins 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 229950004593 ublituximab Drugs 0.000 description 1
• 238000010977 unit operation Methods 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 229950000815 veltuzumab Drugs 0.000 description 1
• 210000001835 viscera Anatomy 0.000 description 1
• 201000005102 vulva cancer Diseases 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 229940045208 yescarta Drugs 0.000 description 1